Kirstin Lloyd
Internal Medicine · Phoenix, AZNPI 1548615644
Payments from drug & device makers
Across 46 payments — averaging $89.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fisher & Paykel Healthcare Inc$2K
- Inspire Medical Systems, Inc.$571
- Jazz Pharmaceuticals Inc.$523
- Harmony Biosciences LLC$190
- ZOLL Respicardia, Inc.$175
- United Therapeutics Corporation$63
- plus $329 from 16 others
What the payments were for
- Speaking & faculty fees$2,25055%
- Travel & lodging$39610%
- Food & beverage$1,25731%
- Education$1975%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FISHER & PAYKEL HEALTHCARE$11,250
- Inspire Upper Airway Stimulation System$571
- remede System$154
- Wakix$112
- XYREM$112
How this compares
$4,100 in reported general payments places this provider in the 90th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 11 | $15,811 |
| Atorvastatin Calcium | 110 | $1,669 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $926 |
| Rosuvastatin Calcium | 35 | $730 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $667 |
| Lisinopril | 67 | $480 |
| Duloxetine Hcl | 23 | $361 |
| Gabapentin | 24 | $333 |
| Omeprazole | 12 | $318 |
| Metoprolol Succinate | 16 | $282 |
| Losartan Potassium | 31 | $236 |
| Metformin Hcl | 27 | $190 |
| Montelukast Sodium | 13 | $182 |
| Levothyroxine Sodium | 26 | $181 |
| Amlodipine Besylate | 30 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $24 | $15,81111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Phoenix
- Louise TaberPhoenix$8.5M
- Ernie RifferPhoenix$3M
- Frank LovecchioPhoenix$945K
- Allison PerrinPhoenix$861K
- Nasser HajaigPhoenix$687K
- Richard TayrienPhoenix$299K
- Sanjay ShahPhoenix$288K
- Kelly KrohnPhoenix$262K
- Paul WaxPhoenix$243K
- Paul StanderPhoenix$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.